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Abstract
Introduction: The use of topical corticosteroids in children and adults, especially in covered areas and for a prolonged duration, may result in Cushing’s syndrome and suppression of the hypothalamic-pituitary-adrenal axis.
Case Presentation: The present report describes the cases of three children and a 25-year-old man who presented with clinical features of Cushing’s syndrome and adrenal insufficiency following prolonged use of clobetasol cream. Two of the children continued with hypertension even after discontinuation of clobetasol, and were treated with angiotensin-converting enzyme inhibitors. One of these two children had developed acute renal failure, hypertensive encephalopathy, and permanent visual loss prior to admission.
Conclusions: Whenever a cushingoid appearance is accompanied by adrenal insufficiency, the exogenous use of steroids, especially topical creams, should be explored. Hypertension may persist even after cessation of use and may result in life threatening complications.
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1. IntroductionTopical corticosteroids are widely used to treat vari-ous skin and inflammatory disorders. However, topical corticosteroid use may lead to several adverse effects. Absorption through the skin may lead to Cushing’s syn-drome with suppression of the hypothalamic-pituitary-adrenal axis (1). Decani et al. (2) reported on the cases of five patients with systemic side effects following the use of topical corticosteroids, whereas 43 cases with exog-enous Cushing’s syndrome over 35 years, two of whom died from severe cytomegalovirus infection, have been reviewed and reported by Tempark et al. (3). The use of clobetasol propionate, a potent corticosteroid, has not been adequately assessed in children, and is therefore not recommended in those aged under 12 years (3).
2. Case PresentationHerein, the cases of three children and a 25-year-old man with a history of topical steroid usage (clobetasol propionate) for diaper rash and dermatitis, respectively, are described. All four cases developed Cushing’s syn-
drome, with life threatening consequences in one case. After a complete physical examination, the children’s height and weight were plotted on CDC 2000 US curves. Standard deviation scores were calculated as patient height minus 50th percentile height/standard deviation for age and sex. Cortisol and adrenocorticotropic hor-mone (ACTH) were measured by electrochemilumines-cence immunoassay (Cobas e411, Roche Diagnostics, Mannheim, Germany).
2.1. Case 1An 11-month-old boy was referred to the endocrine clinic because of irritability and obesity. He was born through normal vaginal delivery at 38 weeks gestation, with a birth weight of 3,250 kg from healthy, unrelated parents. He had an 8-month history of diaper rash and his mother had applied clobetasol propionate oint-ment 0.05%, 6 – 7 times a day, for 4 months, and contin-ued with 3 – 4 daily applications for a further 4 months. On physical examination, he had a blood pressure of 
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170/100 mmHg, a pulse rate of 90 beats/min, body tem-perature of 37°C, and a respiratory rate of 25 breaths/min. A cushingoid appearance, moon face, telangiecta-sia on the cheeks, hypertrichosis and several ecchymot-ic skin lesions were found on the face and limbs (Figure 1). He had a diaper rash with erythematous papules, sug-gestive of candidiasis. His body weight and height were 8.6 kg (between 10th and 25th percentile in the CDC 2000 growth curves) and 64 cm (under 3rd percentile, –4 standard deviation scores), respectively, and he had a head circumference of 45 cm (between 25th and 50th percentile).Blood tests revealed low levels of cortisol and ACTH in the 08:00 AM (Table 1). Other laboratory evaluations were as follows: hemoglobin, 12.4 g/dL; white blood cell, 12,000/mm3; serum creatinine, 0.5 mg/dL; serum so-dium, 136 mEq/L; serum potassium, 4.3 mEq/L; and fast-ing plasma glucose, 114 mg/dL (returned to normal on follow-up). The lipid profile showed higher than normal cholesterol (241 mg/dL) and low-density lipoprotein (164 mg/dL) levels for age and sex, both of which returned to normal on follow-up. Triglyceride and high-density lipo-protein were both normal and 24-h urine-free cortisol was 10 g (normal range, 10 – 100). Serum aldosterone was 114 pg/mL (25 – 313) and renin was elevated (> 500 ng/mL). Echocardiogram, retinal examination, and Dop-pler sonography of the kidneys were normal. Sonogra-phy of the adrenal glands and computerized tomogra-phy of the abdomen and pelvis were normal, without any space-occupying lesions, although mild fatty liver was reported.Topical steroid application was stopped, and the patient was administered a physiological dose of hydrocortisone and gradually tapered. Topical Clotrimazole was applied for skin lesions and a stress dose of hydrocortisone was suggested during illness, fever, and surgery to prevent adrenal crisis. Hypertension was controlled with intrave-nous labetalol, and then changed to enalapril. Figure 2 re-veals the patient’s face after 4 months of discontinuation of hydrocortisone.
2.2. Case 2The patient was a 4-month-old boy referred due to a cushingoid face (Figure 3). He was born full term from unrelated, healthy parents by cesarean delivery. On physical examination, his weight and height were nor-mal, at 6.650 kg (between 25th and 50th percentile) and 63 cm (on 50th percentile), although cushingoid fea-tures were noticed. The mother had applied clobetasol cream on the diaper area since birth until 3 months and 1 week. Despite clinical manifestations of Cushing’s syn-drome, serum cortisol and ACTH were low (Table 1). So-nography of adrenal glands was normal. Arterial blood gas, cell blood count, 3-hour fasting plasma glucose, and the biochemical profile were all normal. The orders for stress were suggested for him and hydrocortisone was not administered. 
Figure 1. An 11-Month-Old Boy (Case 1) Presenting With a Moon Face Appearance and Telangiectasia on the Cheeks
Table 1. Laboratory Tests of the Patients at 08:00 Upon Admission
Cortisol (µg/dL) Adrenocorticotropic 
Hormone (pg/mL)
Case 1Age, mo11 0.72 1.5
Case 2Age, mo4 3.3 18.7
Case 3Age, y3.5 2.14 1.83
Case 4Age, y25 0.5 < 1
Reference values 5 – 16 7.2 – 63
Figure 2. 4 Months After Hydrocortisone was Stopped (Case 1)
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Figure 3. A 4-Month-Old Boy Referred Due to Cushingoid Face
2.3. Case 3This patient was a 3.5-year-old boy with clinical features of Cushing’s syndrome consisting of a round plethoric face, a buffalo hump, and abdominal obesity, which ap-peared at 2 years of age according to his medical report. He had a history of prolonged clobetasol use on the dia-per area. After discontinuation of clobetasol, hydrocorti-sone had been started for adrenal insufficiency. Neverthe-less, hypertension, commonly accompanying Cushing’s syndrome, continued after clobetasol discontinuation. The child had presented with hypertensive encephalopa-thy, acute renal failure, and impaired vision, and there-fore had been treated with angiotensin-converting en-zyme inhibitors. Encephalopathy and renal failure had regressed, but the visual damage was permanent. During renal insufficiency, he had the history of serum sodium and potassium levels of 119 mEq/L and 2.8 mEq/L, respec-tively, which later returned to normal. His laboratory test results are illustrated in Table 1. A tapering and stress dose schedule was given to the parents.
2.4. Case 4The patient was a 25-year-old man who had gained 9 kg in the past 2 years with associated facial fullness and plethora. He had a history of dry skin and had been treat-ed with topical clobetasol ointment 3 times per week on his hands and face (Figure 4).
Figure 4. The Picture of Adult Patient
Figure 5. Patient’s Abdomen Showing Striae (Case 5)
On physical examination, he had a cushingoid-appear-ance with a blood pressure of 143/95 mmHg and a pulse rate of 72 beats/min. His height and weight were 167 cm and 72.5 kg, respectively. He had substantial supraclavicu-lar and dorsocervical fat accumulation (Buffalo hump) and striae on the lower abdomen, arm, and upper thigh (Figure 5). Laboratory findings were as follows: serum sodium, 145 mEq/L; serum potassium, 3.9 mEq/L; fasting blood sugar, 92 mg/dL; creatinine, 0.8 mg/dL; and 24-hour urine-free cortisol, 2.8 µg. Thyroid function tests were normal. Prednisolone at a dose of 7.5 mg/day, divided in 
Razzaghy Azar M et al.
J Compr Ped. 2015;6(4):e343364
two daily doses, was administered and tapered over 3 months. After a further 3 months, cortisol and ACTH lev-els returned to normal.
3. DiscussionThe current report describes the cases of three children presenting with clinical features of Cushing’s syndrome following prolonged treatment of a diaper rash with clo-betasol and that of an adult patient presenting with simi-lar features following clobetasol application on the face and hands. Topical steroids are systemically absorbed and may cause adverse side effects such as iatrogenic Cushing’s syndrome and adrenal suppression due to in-hibition of corticotropin-releasing hormone/ACTH secre-tion (1, 2). Cushing’s syndrome has been reported in both children and adults following the prolonged use of po-tent corticosteroids as topical cream or oral solutions (2-6). Peppa et al. (7) reported that hypertension is less pro-found in exogenous, corticosteroid-induced Cushing’s syndrome; nevertheless, in two of the cases herein, hy-pertension was profound and persisted even after corti-costeroid discontinuation and was accompanied by adre-nal insufficiency. In one patient, the side effects resulted in life threatening events, hypertensive encephalopathy, renal insufficiency with sodium and potassium wasting, and permanent visual loss. In case 1, aldosterone levels were normal but renin levels were high, indicating that aldosterone levels may have been normal at the expense of high renin levels, which may have also lead to high angiotensin (a potent vasopressor) levels, although this was not measured. Despite adrenal insufficiency and dis-continuation of hydrocortisone, hypertension persisted; this is of particular importance in the treatment of pedi-atric patients for whom blood pressure measurement is difficult due to crying of the child. Clobetasol propionate is a potent steroid (600 – 1000 times more potent com-pared to hydrocortisone) and is claimed to have a low skin absorption, nevertheless, all of the patients herein used this drug. Even relatively low doses of this class of steroids (2g/day for 2 weeks) have been associated with adrenal gland suppression. (8, 9) Highly vascular areas, such as the ear canals and areas under occlusion such as the diaper area, have been associated with enhanced systemic absorption (8, 9). Differences in individual sen-sitivity to corticosteroids should also be considered (2). In 1998, Huizenga et al. (10) described a polymorphism in the glucocorticoid receptor gene that was associated with increased receptor sensitivity. N363S mutation has also shown an increase in the therapeutic effect of glu-cocorticoids (2). Mucocutaneous infections are common during corticosteroid treatment, often occurring early in 
the therapy and likely being caused by immunosuppres-sion (10, 11). Whenever a cushingoid appearance is accom-panied by adrenal insufficiency, the exogenous use of steroids, especially topical creams, should be explored. Hypertension may persist even after cessation of use and may result in life threatening complications. The pos-sible complications of long-term topical steroid applica-tions should be appropriately indicated to the patients.
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